chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Blood sugar started to rise /noticed that the sugar was high and previous to the vaccine was low/since the shot was the blood sugar was 200 and high as 300/it's making the blood sugar very high; Headache; Tired; This spontaneous case was reported by a consumer and describes the occurrence of HYPERGLYCAEMIA (Blood sugar started to rise /noticed that the sugar was high and previous to the vaccine was low/since the shot was the blood sugar was 200 and high as 300/it's making the blood sugar very high), HEADACHE (Headache) and FATIGUE (Tired) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A or 030L2CA) for COVID-19 vaccination.   Concurrent medical conditions included Diabetes (insulin dependent) and Hypertension. Concomitant products included INSULIN DEGLUDEC, LIRAGLUTIDE (XULTOPHY) and INSULIN LISPRO (LISPRO INSULIN) for Diabetes.  On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced HYPERGLYCAEMIA (Blood sugar started to rise /noticed that the sugar was high and previous to the vaccine was low/since the shot was the blood sugar was 200 and high as 300/it's making the blood sugar very high), HEADACHE (Headache) and FATIGUE (Tired). At the time of the report, HYPERGLYCAEMIA (Blood sugar started to rise /noticed that the sugar was high and previous to the vaccine was low/since the shot was the blood sugar was 200 and high as 300/it's making the blood sugar very high), HEADACHE (Headache) and FATIGUE (Tired) outcome was unknown.   DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Blood glucose: 200-300 (High) High.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  The patient/reporter stated that she takes a Blood Pressure pill without specifying the name  No treatment information was provided by the reporter.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  The patient's medical history of diabetes on insulin remains a confounder for the event of hyperglycemia.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow-up information was received on 28-Jun-2021 contains information regarding the reporter address details.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  The patient's medical history of diabetes on insulin remains a confounder for the event of hyperglycemia.
09/03/2021 Sharp burning pain in left breast but no problem with nursing  or latching. Significantly reduced and not constant at time of this report. Ongoing.
Sometime within 12 hours from receiving vaccine he had a stroke.  He was taken to the emergency room on January 16, 2021 and tests were performed and he was transferred to Hospital on January 17, 2021.   A MRI was performed on January 17, 2021 and showed that he had suffered a stroke. He was put on blood thinners and sent home on January 18, 2021.  He had an appointment with MD on January 19, 2021. He has appointments with speech therapist, cardiologist and neurologist.
Delayed skin reaction on vaccination site - swelling with redness, warm & firm on shot site Cold compress applied Tylenol (1 tablet) taken
Narrative:  Pt is a 51-year-old male with history of diabetes and bell's palsy who was admitted after ED presentation for evaluation and monitoring of an allergic reaction to COVID-19 booster vaccination. Patient presented with angioedema. He was given methylprednisolone 125 mg IV, diphenhydramine 50mg IV, famotidine 20mg IV, and epinephrine 0.3mg IV in the ED and then admitted overnight to Medicine for observation and monitoring. Patient's angioedema improved with no acute events. He was discharged and COVID-19 vaccine was added to his Allergies/Adverse Reactions on electronic medical record. Patient was referred to the Allergy Clinic after follow up with primary care physician.
ABOUT 3 HOURS AFTER THE SHOT, I HAD A HARD TIME WALKING, I HAD PAIN IN MY SURGICAL SITE OF LOWER BACK L3L4L5. FELT VERY UNSTABE WALKING  AND STARTED WEARING MY BACK BRACE AGAIN,  I HAVE HAD AN MRI  IN JULY AND IM GOING TO THE BACK SURGEON  ON AUGUST 12TH 2021. THE PAIN IS SO INTENSE IN MY BACK AND DOWN MY LEFT LEG, IT FEELS LIKE A KNIFE STABBING ME, I TAKE 3 -800 MG  TABLETS 3 TIMES A DAY, WITH HEAT CREAM OR HEATING PAD. THE ONLY TIME IT DOES NOT HURT IS WHEN I LAY DOWN ON MY BACK.  dose ALSO TAKE OXYCODENE  WHEN IT GETS SO BAD I CANT SLEEP.
Pt developed some swelling and redness on upper thigh area (4.5cm). He was treated with ice. Call back to mother on 8/24/01 revealed pt doing fine.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Nov2022 at 16:00 as dose 4 (booster), single (Lot number: GJ3277) at the age of 43 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Panelist, reaction(s): "Known allergies: Panelist". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: negative results for the past 6 days. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: No other medication in 2 weeks. The patient received Paxlovid from 27Feb2023 to 02Mar2023.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300108759 same patient, different drug and event;
Left upper arm where vaccine was given became swollen, rede and painful. Patient complained of this for 2 days. Ultrasound of arm was negative.
Fussy, crying in pain, refusing bottles, had small mucusy bloody stool the morning of 4/15. seen in the office, diagnosis obscure, had large bloody stool that evening. ED dx intussuseption. Reduced with air enema. Did well.
1) Nerve issue/cramping in 3 fingers on left hand; 2) Persistent headache in different sections of my head, more pronounced on right side of head & in a cluster); 3) Standard responses: fever, chills, body ache, run down feeling, and mild swelling in throat.
2/7/23 ? I had a very sudden attack of fatigue, headache and dizziness to where I could not work anymore. I was unable to drive. I called my doctor?s office, and they had no appointment available, so I went to the Emergency Room.  I had a lot of tests and did not find a cause for my symptoms.  I followed up with my family doctor twice after that within a period of two weeks. I tried two prescriptions which did not help. I had an MRI of my head on 3/11/23 that was normal. I had an appointment with my doctor on 3/30/23. I had bloodwork. I will get the results tomorrow. My symptoms are continuing.
Pt. claims had reaction to vaccine. Symptoms included headache, fever (temp. unknown), chills, severe back pain, per pt. phone call on 9/20. Attempted to follow-up several times and pt. finally called back 9/27 and indicated she is all better now. "Doing fine".
Receiving doses after the beyond use date/ Thaw expiration date was 3/2/2022, date administrered was on 5/5/2022 8:16 PM; Receiving doses after the beyond use date/ Thaw expiration date was 3/2/2022, date administrered was on 5/5/2022 8:16 PM; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Receiving doses after the beyond use date/ Thaw expiration date was 3/2/2022, date administrered was on 5/5/2022 8:16 PM) and PRODUCT STORAGE ERROR (Receiving doses after the beyond use date/ Thaw expiration date was 3/2/2022, date administrered was on 5/5/2022 8:16 PM) in a 24-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 045L21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2022 at 8:16 PM, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 05-May-2022 at 8:16 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Receiving doses after the beyond use date/ Thaw expiration date was 3/2/2022, date administrered was on 5/5/2022 8:16 PM). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Receiving doses after the beyond use date/ Thaw expiration date was 3/2/2022, date administrered was on 5/5/2022 8:16 PM). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Receiving doses after the beyond use date/ Thaw expiration date was 3/2/2022, date administrered was on 5/5/2022 8:16 PM) and PRODUCT STORAGE ERROR (Receiving doses after the beyond use date/ Thaw expiration date was 3/2/2022, date administrered was on 5/5/2022 8:16 PM) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was reported that the HCP administered the vaccine after the beyond use date, as the HCP didn't know that the vials shouldn't be used past 30 days from thawing the vials. Vials were initially stored on 31-Jan-2022. Thaw expiration date was 02-Mar-2022. The vial did not undergo any temperature excursion. No treatment medications were reported.
7/23/2022 Presented with complaints of weakness. Symptoms began possibly 2 days ago. Hospitalized with concerns of COVID infection without evidence of pneumonia. History of CHF with concerns of mild acute exacerbation, also elevated cardiac enzyme.  Febrile at 101.3F on admission, O2 2L after desat to 83. Plan to be started on doxycycline, dexamethasone along with albuterol as needed and supplemental oxygen therapy as needed for the COVID infection. CHF to be treated with Lasix 40 mg IV daily along with cardiac monitoring with telemetry and echocardiogram.  Supplemental oxygen, wean as tolerated. -Albuterol PRN, no duonebs or aerosolizing procedures. -Remdesivir- not a candidate, no PNA -Dexamethasone 6mg 10d. - Empiric abx with Doxy -Covid labs per protocol -Home oxygen evaluation possible prior to DC.
slight pain in their arm; This is a spontaneous report received from a Pfizer sponsored program. A contactable consumer (wife) reported that a male patient of an unknow age received BNT162B2 (Solution for injection) via an unknown route on 18Mar2021, at an unknown dose and single for COVID-19 immunization. The patient's medical history was not reported. The concomitant medication were not reported. The consumer reported that she, her mother, and her husband got the first dose last Thursday. The consumer would like to know the timeframe of getting the second dose. The caller said she wishes to get her second dose later (22 days or 25 days) so that she can take care of her 90-year-old mother in case she gets any side effects. The consumer mentioned that they have experienced slight pain in their arm after the first dose. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
5 hours post injection fever 103 degrees persisting for 2 days, sore eyes and body aches wit.h dry cough. Still fever at time of report.
I experienced a severely tender, swollen lymph node in my armpit; I experienced a severely tender, swollen lymph node in my armpit; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 07Mar2021 at 16:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included uncontrolled asthma, anxiety and celiac. The patient had known shellfish allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amitriptyline hydrochloride (ELAVIL) and montelukast sodium (SINGULAIR); all taken on an unknown date for an unknown indication and unknown if ongoing. On 13Mar2021, approximately 1 week after vaccine, the patient experienced a severely tender, swollen lymph node in armpit. It was the same arm as the injection site. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events the patient experienced a severely tender, swollen lymph node in the armpit was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 58-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 30Sep2022 at 01:00 as dose 5 (booster), single (Lot number: Fk9m9693) at the age of 57 years, in left arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 15Mar2021 at 10:00 as dose 1, single (Lot number: En6203), in left arm, on 05Apr2021 at 12:00 as dose 2, single (Lot number: Ep6955), in left arm, on 09Nov2021 as dose 3 (booster), single (Lot number: Fg3527), in left arm and on 27Apr2022 at 12:00 as dose 4 (booster), single (Lot number: Fk9893), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Breast cancer survivor" (unspecified if ongoing), notes: Breast cancer survivor. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 (Paxlovid received). Additional information: No known allergy.
Client became lightheaded, dizzy and nauseated very shortly after injection. Juice given, cool cloths applied to head and neck. Needed to move to BR via WC, placed on bed with cool pack behind neck and knees elevated. Pulse 60 BP 114/76. Alert and oriented and speaking throughout incident. Client has had pacemaker x 8 yrs - due to be replaced. Stated sx's are similar to sxs she had prior to pacemaker. Family doctor notified of event. She recommended evaluation at ER. Friend came and drove her to ER for evaluation. Tuesday, June 25, 2013 at 3:05pm. Phone call received from patient. RN spoke with her. She was seen in the ER. They checked blood work, did an EKG and a pacemaker check. They've determined that she is dehydrated. The EKG and pacemaker check were both normal. She is home now forcing fluids. The ER will be notifying her Cardiologist of this incident.
I had worst medical help when I sought medical care, did not return my calls, once I got tested for COVID, I came up positive. They would not let me in the clinic. My doctor never got in contact with me. It took like 2 and half days to get them to call in a prescription for me, cough medicine. I experienced illness, throat starting to hurt, left nostril was tingling and would not stop running, felt like I had a cold, i thought I had COVID. I went to get a COVID test the next day and it was negative. I had these symptoms for three days. I still have symptoms today, I have COVID and pneumonia, attack my lungs. I went to urgent care and they injection with Regeneron, antibiotic and called in list of prescriptions for me. They put me on Prednisone medication, Ibuprofen medication and also cough medicine, the cough medicine did not work and the next day I went to ER. At the ER they admitted me, labwork, chest x-ray were performed and put me on all kinds of antibiotics. They also put me on a steroid medication the Regenerol cocktail for two days and I was able to get oxygen level. My oxygen level was 93. I am now taking two breathing treatments, I am on two antibiotics and on steroid medication, have me also on cough medicine. I also have a breathing machine.
Dry mouth; Hands feel like two balloons; Tongue felt swollen; Tired; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry mouth), PERIPHERAL SWELLING (Hands feel like two balloons), SWOLLEN TONGUE (Tongue felt swollen), FATIGUE (Tired) and HEADACHE (Headache) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     Concurrent medical conditions included Epilepsy and Acromegaly.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced DRY MOUTH (Dry mouth), PERIPHERAL SWELLING (Hands feel like two balloons), SWOLLEN TONGUE (Tongue felt swollen), FATIGUE (Tired) and HEADACHE (Headache). At the time of the report, DRY MOUTH (Dry mouth), PERIPHERAL SWELLING (Hands feel like two balloons), SWOLLEN TONGUE (Tongue felt swollen), FATIGUE (Tired) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
case fully vaccinated with moderna. Second dose administered on 2/12/2021. Also had booster dose of moderna on 10/25/2021. Tested positive for COVID on 11/2/2021. Admitted to Hospital 11/02/2021. Expired on 11/08/2021 while still hospitalized.
This spontaneous report has been received from a physician via a company representative referring to a 24 year old female patient. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On unknown dates, (reported as "in her teens") the patient complete the three-dose series of GARDASIL for prophylaxis (dose, route of administration, lot number and expiration date were not reported). On an unknown date, the patient experienced pap smear which was abnormal. Further unspecified testing determined that the patient was positive for human papillomavirus (HPV) type 16 infection (papilloma viral infection). At the time of reporting, the outcome of pap smear and papilloma viral infection was unknown. Additionally, the reporter did not provide causal relationship between the events and therapy with GARDASIL.
Patient has a history of anaphylaxis to bee stings and was monitored for 30 minutes. He experienced lightheadedness at about 25 minutes after injection, lasted about 10 minutes, facility dr monitored patient and checked him out. Episode of lightheadedness was resolved.
pt recv vax JUL97 & a few days post vax inj site swelled & resulted in small nodules which subsequently resolved over the weekend;
Patient complained of soreness when moving arm laterally for a week post vaccination.  Pt was advised to use a heating pad and motrin as needed.  If pain continued to persist to visit PCP.  Patient's pain resolved. A month later the pain resumed. Patient was advised to make an appointment with PCP.
Bell's palsy. Treated with steroid and antiflammatory. Seems to be a mild case, and I am improving, but am not fully recovered.
pt recv vax 2APR97 & bridge of nose swelled & got very tender (as if broken);3APR (eased off a little 4APR);
Burning, itching, severe swelling of the left arm for 2 weeks.  Unable to use the left arms for at least a week.  I was unable to even sleep on the left arm due to pain and swelling.
covid test date=27/Nov/2021 / covid test result=Positive; covid test date=27/Nov/2021 / covid test result=Positive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 66 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Oct2021 16:00 (Lot number: FD0810) at the age of 66 years as dose 3 (booster), single, administered in arm left, administration date 08Mar2021 15:00 (Lot number: EN6203) as dose 2, single and administered in arm left, administration date 15Feb2021 16:00 (Lot number: EN5318) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Acid reflux" (unspecified if ongoing). Concomitant medication(s) included: PRILOSEC [OMEPRAZOLE]. Past drug history included: Tetracycline, reaction(s): "Drug allergy"; Erythromycin, reaction(s): "Drug allergy". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 27Nov2021, outcome "not recovered" and all described as "covid test date=27/Nov/2021 / covid test result=Positive". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (27Nov2021) positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Patient stated that severe hives rash itching inflammation dry peeling skin located on my face eyes lips neck and the outside of both hands. Treatment received with : 4 rounds Steroids / Pepcid Zyrtec Allegra etc.
Acute Zoster L5S1 not sure if related, prob stress from THR, but question was any need to visit a doctor since last covid-19 vaccine
Dose administered greater than 12 hours post puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered greater than 12 hours post puncture) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017f21a) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered greater than 12 hours post puncture). On 07-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Dose administered greater than 12 hours post puncture) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided by the reporter. No treatment information provided. The vial was initially stored in the refrigerator on 30-Nov-2021. The vial was first punctured on 30-Nov-2021.
This spontaneous report as received from a pharmacist concerning a 59 years old female patient who on 08-SEP-2012 vaccinated with an expired dose ZOSTAVAX (lot # 670820/0660AA, Exp. 04-AUG-2012) (dose and route not reported). The consumer's relevant medical history, concomitant medications, and past drug history are unknown. It was unknown if there was any relevant laboratory data. As of 08-SEP-2012, it was unknown if the consumer continued taking ZOSTAVAX. Additional information has been requested.
On April 15, I noticed a pain in my right armpit. It was an achey sore pain, but also a more sharp, prominent pain at certain times. So I think it was a swollen lymph node. But by April 18 and 19, it only hurts when I raise my arm.   And also on April 15, my right arm was little itchy at the injection site, but I didn?t think anything of it. But by April 17, my whole upper right arm was very itchy, red, and warm to the touch. This has continued for the past few days. It?s not all the time, but a few times throughout the day and it lasts for probably a half hour to an hour.